Results 271 to 280 of about 610,904 (340)

The Implementation of Early Intervention Initiatives for Psychosis in Latin America and the Caribbean: A Case Study. [PDF]

PLOS Glob Public Health
Valle R, Velez C, Iyer SN.
europepmc   +1 more source

Reporting Societal : Limites Et Enjeux De La Proposition De Normalisation Internationale " Global Reporting Initiative "

, 2003
Michel Capron, Françoise Quairel
openalex   +1 more source

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket, J. Lycke, J. Salzer, F. Piehl, K. Fink, N. Lange, J. Mellergård, C. Malmeström, P. Sundström, I. Erngren, A. al‐Grety, E. Freyhult, K. Kultima, J. Burman, A. Svenningsson   +14 more
wiley   +1 more source

Associations of baseline characteristics, patient-reported outcomes, and satisfaction with pain therapy with the patient's global impression of change: a prospective cohort study. [PDF]

Br J Anaesth
Roper L, Belton J, Weinmann C, Fletcher D, Lavand'homme P, Kalso E, Meissner W, Rosenberger DC, Segelcke D, Vollert J, Pogatzki-Zahn EM.   +10 more
europepmc   +1 more source

Atendimento de instituições financeiras às recomendações de evidenciação ambiental da Global Reporting Initiative (GRI)

, 2015
Geovana Zimmermann Los, Ernani Ott, Patrícia Schneider Severo, João Eduardo Prudêncio Tinoco   +3 more
openalex   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Commentary: CRISPR-Cas systems against carbapenem resistance-from proof-of-concept to clinical translation. [PDF]

Front Microbiol
D J, Mulavagili S, Vijayasimha M.
europepmc   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

Evaluating the implementation of the 'Patient Safety Caravan' for patient engagement in Riyadh, Saudi Arabia. [PDF]

BMC Health Serv Res
AlKhalil R, Aldalbahi F, Al-Wathnani A, Majrashi M, Alshabib T, AlFayyad I.   +5 more
europepmc   +1 more source

A Study of Environmental Disclosures in the European Oil and Gas Industry : With Reference to the Global Reporting Initiative

, 2016
Emma Pettersson, Martina Engvall
openalex   +1 more source